专利号:US-8901352-B2 优先权日:2011-01-13 标题 :Method for the synthesis of rasagiline 发明人:REIS ÖMER; KOYUNCU HASAN; ESIRINGU ILKER; SAHIN YASEMIN; GULCAN H OZAN 权利人:REIS ÖMER; KOYUNCU HASAN; ESIRINGU ILKER; SAHIN YASEMIN; GULCAN H OZAN; NOBEL ILAÇ SANAYII VE TICARET A S 摘要:We have developed a new method for the synthesis of Rasagiline (Formula 1) based on the alkylation of trifluoroacetyl protected aminoindan. This protection enabled us to carry out an alkylation of aminoindan with a high yield and purity under very mild conditions with a wide range of reaction conditions and reagent selection. Considering the ease, purity and high yields of introducing and removal of the trifluoroacetyl group, this approach is a highly practical and economical way for the synthesis of rasagiline or its pharmaceutically acceptable salts.
专利号:US-12201669-B2 优先权日:2021-03-11 标 题:Small molecule suppressors of APOE gene expression and cerebral vascular amyloid pathology 发明人:TSAI LI-HUEI; BLANCHARD JOEL 权利人:MASSACHUSETTS INST TECHNOLOGY 摘要:The present disclosure provides methods of inhibiting amyloid synthesis in a subject using small molecule inhibitors. The invention also includes methods of treating disease associated with amyloid synthesis, such as Alzheimer's disease. The small molecule inhibitors disclosed herein are compounds which are non-immunosuppressant cyclosporin including the pharmaceutically acceptable salts thereof.
专利号:WO-2009081148-A1 优先权日:2007-12-24 标 题:Process for the synthesis of propargylated aminoindan derivatives
专利号:CA-2708820-A1 优先权日:2007-12-24 标题 :Process for the synthesis of propargylated aminoindan derivatives
专利号:AU-2008339607-A1 优先权日:2007-12-24 标题:Process for the synthesis of propargylated aminoindan derivatives
专利号:EP-2663545-A1 优先权日:2011-01-13 标 题 :A new method for the synthesis of rasagiline
1: Müller T. Pharmacokinetic/pharmacodynamic evaluation of rasagiline mesylate for Parkinson's disease. Expert Opin Drug Metab Toxicol. 2014 Oct;10(10):1423-32. doi: 10.1517/17425255.2014.943182. Epub 2014 Sep 6. 155(3):187-194. Japanese. doi: 10.1254/fpj.19146. 78(3):1023-1028. doi: 10.22092/ARI.2022.360193.2563. 4: Mahde BW, Abbas Hussein A, Alsaraf KM, Abdelamir Mohammad H. Transdermal Microneedle-Mediated Delivery of Rasagiline Nanoparticles. Arch Razi Inst. 2023 Jun 30;78(3):1017-1022. doi: 10.22092/ARI.2022.360192.2562. 5: Rabey JM, Sagi I, Huberman M, Melamed E, Korczyn A, Giladi N, Inzelberg R, Djaldetti R, Klein C, Berecz G; Rasagiline Study Group. Rasagiline mesylate, a new MAO-B inhibitor for the treatment of Parkinson's disease: a double-blind study as adjunctive therapy to levodopa. Clin Neuropharmacol. 2000 Nov- Dec;23(6):324-30. doi: 10.1097/00002826-200011000-00005. 4(4):330-46. doi: 10.1016/j.amjopharm.2006.12.001. 4(3):331-340. doi: 10.1002/ehf2.12140. Epub 2017 Mar 12.
合成参考文献
摘要:González-Granda, S.; Gotor-Fernández, V., Science of Synthesis, (2022) , 231. 参考文献:10.1007/s007020200038 摘要:Maruyama W, Takahashi T, Youdim M, Naoi M. The anti-Parkinson drug, rasagiline, prevents apoptotic DNA damage induced by peroxynitrite in human dopaminergic neuroblastoma SH-SY5Y cells. J Neural Transm (Vienna). 2002 Apr;109(4):467–81. doi: 10.1007/s007020200038. 参考文献:10.1186/s13256-017-1202-x 摘要:Ibrahim FAB, Rashid F, Hussain AAB, Alawadi F, Bashier A. Rasagiline-induced severe recurrent hypoglycemia in a young woman without diabetes: a case report. Journal of Medical Case Reports. 2017 Feb 02;11(1):29. doi: 10.1186/s13256-017-1202-x. 参考文献:10.2165/00002512-200623070-00008|10.2165/00002512-200623080-00005|10.2165/00002512-200623090-00009|10.2165/00002512-200623100-00008|10.2165/00002512-200623110-00007|10.2165/00002512-200623120-00007 摘要:Gerontology forum: an update on the literature. Drugs Aging. 2006;23(8):681–92. doi: 10.2165/00002512-200623080-00005.